The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye ...

Launching a successful side hustle requires embracing your passion and life experience. Many, or all, of the products featured on this page are from our advertising partners who compensate us when ...

Three hours...if that's all the time you have to work on your side hustle, that's all the time you need. After all, a side hustle is meant to be just that—a project you do on the side.

The agreement with Poseida is by far the larger of the two, with Roche paying $110 million upfront to license rights to off-the-shelf CAR-T therapies aimed at haematological cancers, including one ...

1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

I've been building side hustles for years, and they now earn me almost $15,000 a month. When I got hired at Capital One, I was worried about a full-time job disrupting my side hustles, but I've ...

Fenebrutinib is currently the only reversible, non-covalent inhibitor of BTK in late-stage development, which Roche maintains could translate into a cleaner side effect profile than other drugs in ...

When combining insights from Morningstar Sustainalytics ESG Risk Ratings and Morningstar Equity Research (depicted in Exhibit 1), we find that Pfizer PFE and Roche RHHBY stand out as potential top ...

A day before the deadline for the first phase of an agreement that ended the war between Israel and the Hezbollah militant group, a team from the Associated Press accompanied a UNIFIL peacekeeping ...